Drug-related pellagra in a Ugandan woman on isoniazid preventative therapy

被引：6

作者：

Coates, Sarah J. ^{[1
,2
]}

Blasini, Amy W. ^{[3
,4
]}

Musinguzi, Patrick ^{[5
,6
]}

Laker-Oketta, Miriam ^{[2
,5
]}

机构：

[1] Univ Calif San Francisco, Dept Dermatol, 1701 Divisadero St,Suite 4-20, San Francisco, CA 94143 USA

[2] Infect Dis Inst, Kampala, Uganda

[3] Univ Michigan, Sch Med, Ann Arbor, MI USA

[4] Makerere Univ, Sch Publ Hlth, Kampala, Uganda

[5] Makerere Univ, Coll Hlth Sci, Kampala, Uganda

[6] Mulago Natl Referral Hosp, Dermatovenereol Div, Kampala, Uganda

来源：

IDCASES | 2020年 / 20卷

基金：

美国国家卫生研究院;

关键词：

IPT; Latent tuberculosis; Adverse drug reaction; HIV;

D O I：

10.1016/j.idcr.2020.e00750

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

[No abstract available]

引用

页数：2

共 4 条

[1]

Darvay A, 1999, CLIN EXP DERMATOL, V24, P167

[2] Pellagra in isoniazid preventive and antiretroviral therapy [J].

Kipsang, John Koech ;

Choge, Joseph K. ;

Marinda, Pamela A. ;

Khayeka-Wandabwa, Christopher .

IDCASES, 2019, 17

[3]

Ministry of Health Uganda, 2016, UG CLIN GUID 2016

[4] Treatment with isoniazid or rifampin for latent tuberculosis infection: population-based study of hepatotoxicity, completion and costs [J].

Ronald, Lisa A. ;

FitzGerald, J. Mark ;

Bartlett-Esquilant, Gillian ;

Schwartzman, Kevin ;

Benedetti, Andrea ;

Boivin, Jean-Francois ;

Menzies, Dick .

EUROPEAN RESPIRATORY JOURNAL, 2020, 55 (03)

← 1 →